Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Aquestive Therapeutics
AQST
$553M
| $104K | ﹤0.01% |
31,328
-21,836
| -41% | -$62.6K |
|
4227
Perion Network
PERI
$379M
| $104K | ﹤0.01% |
+10,212
| New | +$97.6K |
|
4228
Monte Rosa Therapeutics
GLUE
$1.34B
| $103K | ﹤0.01% |
22,913
-8,201
| -26% | -$36.6K |
|
4229
Nathan's Famous
NATH
$399M
| $103K | ﹤0.01% |
934
-1,065
| -53% | -$109K |
|
4230
IBEX
IBEX
$491M
| $103K | ﹤0.01% |
3,549
-2,994
| -46% | -$80.1K |
|
4231
Treace Medical Concepts
TMCI
$308M
| $103K | ﹤0.01% |
17,508
-17,750
| -50% | -$116K |
|
4232
DocGo
DCGO
$57.4M
| $103K | ﹤0.01% |
65,543
-10,630
| -14% | -$19.8K |
|
4233
Gevo
GEVO
$403M
| $103K | ﹤0.01% |
77,902
+74,863
| +2,463% | +$87.7K |
|
|
SRTA
4234
Strata Critical Medical Inc
SRTA
$533M
| $103K | ﹤0.01% |
25,505
-15,199
| -37% | -$49.5K |
|
4235
Movado Group
MOV
$822M
| $103K | ﹤0.01% |
6,733
-5,612
| -45% | -$85.8K |
|
4236
Colony Bankcorp
CBAN
$468M
| $102K | ﹤0.01% |
6,204
-6,513
| -51% | -$101K |
|
4237
Franklin Covey
FC
$235M
| $102K | ﹤0.01% |
4,469
-3,987
| -47% | -$88.1K |
|
4238
FlexShares Credit-Scored US Corporate Bond Index Fund
SKOR
$736M
| $102K | ﹤0.01% |
2,090
+140
| +7% | +$6.73K |
|
4239
The RMR Group
RMR
$337M
| $101K | ﹤0.01% |
6,171
-5,203
| -46% | -$79.7K |
|
4240
Mama's Creations
MAMA
$828M
| $100K | ﹤0.01% |
12,105
-11,314
| -48% | -$81.5K |
|
|
DOO
4241
Bombardier Recreational Products
DOO
$4.79B
| $100K | ﹤0.01% |
2,074
-108
| -5% | -$4.26K |
|
4242
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
| $100K | ﹤0.01% |
1,200
| – | – |
|
4243
Bankwell Financial Group
BWFG
$542M
| $99.7K | ﹤0.01% |
2,767
-2,096
| -43% | -$69.7K |
|
4244
The 3D Printing ETF
PRNT
$65.3M
| $99.5K | ﹤0.01% |
+4,551
| New | +$92.2K |
|
4245
Orange County Bancorp
OBT
$520M
| $99.3K | ﹤0.01% |
3,842
-3,773
| -50% | -$92.1K |
|
|
RZLV
4246
Rezolve AI
RZLV
$1.11B
| $99.2K | ﹤0.01% |
+32,268
| New | +$63.6K |
|
|
VTYX
4247
DELISTED
Ventyx Biosciences
VTYX
| $99.1K | ﹤0.01% |
46,330
+1,278
| +3% | +$2.06K |
|
4248
Richtech Robotics
RR
$389M
| $98.7K | ﹤0.01% |
50,622
+49,621
| +4,957% | +$104K |
|
|
PHLT
4249
DELISTED
Performant Healthcare Inc
PHLT
| $98.3K | ﹤0.01% |
24,566
-26,240
| -52% | -$74.4K |
|
4250
Target Hospitality
TH
$1.66B
| $98K | ﹤0.01% |
13,770
-13,393
| -49% | -$93K |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.